Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CLSI Publishes New Guideline for Continuous Interstitial Glucose Monitoring.


WAYNE, Pa. -- Continuous interstitial glucose monitors (CGM (1) (Computer Graphics Metafile) An ISO/IEC standard format for 2D graphics images introduced in 1987. Primarily a vector graphics format for technical illustrations and geophysical visualizations, CGM also supports raster graphics and text. ) are medical devices that measure glucose in the interstitial fluid interstitial fluid
n.
The fluid in spaces between the tissue cells.


Interstitial fluid
The fluid between cells in tissues. Referred to as the liquid subtance of the body.

Mentioned in: Lymphedema
 just under the skin. CGM offers the patients the potential of monitoring their glucose and managing insulin levels without repeated finger sticks. Because CGM offers the ability to report trends in glucose levels over time, the development of new evaluation methods for determining the accuracy of CGM devices is necessary. As more manufacturers develop CGM devices, consistent evaluation protocols become more important.

Clinical and Laboratory Standards Institute (CLSI CLSI Clinical and Laboratory Standards Institute (Wayne, PA)
CLSI Cisco Link Services Interface
) has recently published a new document, Performance Metrics for Continuous Interstitial Glucose Monitoring glucose monitoring Lab medicine The periodic evaluation of any analyte abnormal in Pts with DM, to assess short and long-term control with antiglycemic agents. See Glucose, Glycated hemoglobin. ; Proposed Guideline (POCT POCT Point of care testing, see there 5-P), which specifies requirements and recommendations for methods for determining analytical and clinical metrics of CGM.

David Klonoff, MD, FACP FACP Fellow of the American College of Physicians.

FACP
abbr.
1. Fellow of the American College of Physicians

2. Fellow of the American College of Prosthodontists
, Diabetes Technology Society, and chairholder of the CLSI subcommittee that developed the guideline, explains, "The POCT5-P document presents the use of CGM--how to present the data, how to compare the data between different continuous interstitial glucose monitors, and how to compare the data with spot blood testing. These guidelines should help save time and effort in developing new products by establishing for the manufacturers how the products must perform."

The guideline defines multiple aspects of analyzing CGM performance data including:

* point accuracy;

* trend accuracy;

* sensitivity and specificity;

* device stability;

* calibration;

* lag time; and

* trueness of measurement and device traceability.

For additional information on CLSI or for further information regarding this release, visit our website at http://www.clsi.org or call +610.688.0100.

CLSI, formerly NCCLS NCCLS National Committee for Clinical Laboratory Standards , is a global, nonprofit, membership-based organization dedicated to developing standards and guidelines for the health care and medical testing community. CLSI's unique consensus process facilitates the creation of standards and guidelines that are reliable, practical, and achievable for an effective quality system.
COPYRIGHT 2008 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 22, 2008
Words:289
Previous Article:3M Cold Shrink Branch Splice Is Available.
Next Article:Jelec USA Inc. Becomes Ascom(R) Strategic Certified Solution Partner.
Topics:



Related Articles
SPECTRX/ABBOTT TO DEVELOP CONTINUOUS GLUCOSE MONITOR.
Emerging technology in diabetes mellitus: glucose monitoring and new insulins. (Review Article).
MINIMAL-INVASIVE BLOOD GLUCOSE MEASUREMENT WITHOUT BLOOD.
Specimen-collection standards complete major revisions.
EQC's future sparks continued dialogue.
Interlinking processes and procedures: new guideline for development and control of lab documents.
CLSI evaluation protocols.
Driving innovation in diabetes care: new diabetes treatment and monitoring technology means opportunity for both patients and medical device...
Basics of home glucose monitoring.
Diabetes Control - Expert Q&A - Closing the Loop on Diabetes Control

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles